Newsroom

News, press release, announcements, and more, pertaining to 3billion.
12 posts
Newsroom

3billion receives accreditation from the College of American Pathologists

3billion has received CAP accreditation on November 15th. CAP accreditation is an evaluation system by the College of American Pathologists, an organization of clinical pathologists in…

Newsroom

3billion selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul

On December 8th, 3billion was selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul for the ‘Genetic retinal disease’ category. 3billion was highly…

Newsroom

Immediate Diagnosis Through Collaboration with Dr. Alisdair McNeill

Immediate Diagnosis Through Collaboration with Dr. Alisdair McNeill “I was surprised that such a recent publication would be incorporated into clinical reporting so rapidly.  It is…

Newsroom

3billion announces Dr. Hane Lee of UCLA as Chief Clinical Geneticist

3billion announces Dr. Hane Lee of UCLA as Chief Clinical Geneticist 3billion has announced Dr. Hane Lee, a former UCLA professor of pathology/diagnostic medicine and…

Newsroom

3billion looks to 2022 IPO, expansion into drug discovery

The Korean startup, having only been founded in October 2016, is already on track to go public in early 2022 on the KOSDAQ. The KOSDAQ and…

Newsroom

Rare disease screening firm 3Billion closes $13M Series C financing

Rare Disease Screening Firm 3Billion Closes $13M Series C Financing The Korean startup 3billion has officially closed its Series C funding by raising $13 million. They…

Newsroom

3billion aims for the global market by IPO

3billion Aims for the Global Market by IPO 3billion, an AI-based rare disease genetic diagnosis startup, aims for the global market by IPO. 3billion has selected…

Newsroom

3billlion named "Next Unicorn" at ASEAN-Korea

Korean Genetic Testing Firm 3billlion Named "Next Unicorn" at ASEAN-Korea Scale-up Contest 3billion wins the "Next Unicorn" award in the 'ASEAN-Korea Scale-up…

Newsroom

3billion CEO Changwon Keum: "We diagnose 7,000 rare diseases at once using AI"

3billion CEO Changwon Keum "We diagnose 7,000 rare diseases at once using AI" In an interview with Seoul Economic Daily, Changwon Keum, CEO…

Newsroom

Korean genetic testing firm makes genetic test for rare diseases affordable

Korean Genetic Testing Firm Makes Genetic Test for Rare Diseases Affordable3billion announces that for a service fee of $699, it can diagnose over 7,000 rare…

Newsroom

Korean rare disease diagnostics firm 3billion raises $10M

Korean Rare Disease Diagnostics Firm 3billion Raises $10M 3billion raises $10 million in a Series B financing round, led by Korea Development Bank. Other investors included…

Subscribe to our newletter

Get email updates on 3billion's announcements & updates, clinical cases, and rare disease information

Thank you for
subscribing 👏